article Open AccessTop 1% cited
The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study
Journal of the American Academy of Dermatology · 2011 · Vol. 65(1) · pp. 25–34
David Fiorentino✉(Stanford Medicine)Leland W.K. Chung(VA Palo Alto Health Care System)Jeff Zwerner(Stanford University)Antony Rosen(Johns Hopkins University)Livia Casciola‐Rosen(Johns Hopkins University)
Inflammatory Myopathies and DermatomyositisEosinophilic Disorders and SyndromesSkin Diseases and DiabetesMedicineMucocutaneous zoneDermatomyositisDermatologyAntibodyImmunologyPathologyDisease
MeSH terms
Interferon-Induced Helicase, IFIH1AdultAutoantibodiesBiopsy, NeedleDermatomyositisFemaleGene Expression RegulationHumansImmunohistochemistryMaleMiddle AgedMonitoring, PhysiologicPeptidesPhenotypePrognosis
Citations
545
FWCI
16.77
field-weighted impact
References
44
Percentile
100%
vs. same field & year
Citations per year
References
A New Approach to the Classification of Idiopathic Inflammatory Myopathy
Medicine · 1991 · 970 citations
The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody
Lara D. Veeken · 2009 · 330 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.